Latest 蘑菇影院 Health News Stories
蘑菇影院 Health News' 'What the Health?': Countdown to Shutdown
Congress appears to be careening toward a government shutdown, as a small band of House conservatives vow to block any funding for the fiscal year that begins Oct. 1 unless they win deeper cuts to health and other domestic programs. Meanwhile, former President Donald Trump continues to roil the GOP presidential primary field, this time with comments about abortion. Alice Miranda Ollstein of Politico, Rachel Cohrs of Stat, and Tami Luhby of CNN join 蘑菇影院 Health News chief Washington correspondent Julie Rovner to discuss these issues and more. Also, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.
Save Billions or Stick With Humira? Drug Brokers Steer Americans to the Costly Choice
Thousands of patients with autoimmune diseases who rely on Humira, with a list price of $6,600 a month, could get financial relief from new low-cost rivals. So far, the pharmacy benefit managers that control drug prices in America have not delivered on those savings.
Humira lleva 20 a帽os disfrutando de una exclusividad muy cara en el pa铆s. Sus competidores podr铆an ahorrarle al sistema sanitario $9,000 millones.
Por qu茅 los CDC recomiendan el nuevo refuerzo contra covid para todos
El Comit茅 Asesor sobre Pr谩cticas de Inmunizaci贸n de los CDC vot贸 13-1 a favor de la moci贸n despu茅s de meses de debate sobre si limitar los refuerzos a grupos de alto riesgo.
Why the CDC Has Recommended New Covid Boosters for All
As covid-19 hospitalizations tick upward with fall approaching, the CDC says it鈥檚 time for new boosters 鈥 and not only for those at highest risk of serious disease. Here are seven things you need to know.
Journalists Recap How Smallpox Was Wiped Out and How Opioid Settlement Cash Is Being Paid Out
蘑菇影院 Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
蘑菇影院 Health News' 'What the Health?': Welcome Back, Congress. Now Get to Work.聽
Congress returns from its summer recess with a long list of tasks and only a few work days to get them done. On top of the annual spending bills needed to keep the government operating, on the list are bills to renew the global HIV/AIDS program, PEPFAR, and the community health centers program. Meanwhile, over the recess, the Biden administration released the names of the first 10 drugs selected for the Medicare price negotiation program.
Artificial Intelligence May Influence Whether You Can Get Pain Medication
To contain the opioid crisis, health and law enforcement agencies have turned to technology to monitor doctor and patient prescription data. Experts have raised questions about how these systems work and worry about their accuracy and potential biases. Some patients and doctors say they鈥檙e being unfairly targeted.
5 Things to Know About the New Drug Pricing Negotiations
The Biden administration unveiled the first 10 drugs subject to price negotiations, taking a swipe at the pharmaceutical industry. But what does it mean for patients?
Sin barreras, los precios de algunos medicamentos existentes se han disparado, incluso cuando han ca铆do dr谩sticamente en otros pa铆ses. Los nuevos medicamentos tienen precios enormes, respaldados por el lobby y el marketing.
A Peek at Big Pharma鈥檚 Playbook That Leaves Many Americans Unable to Afford Their Drugs
Brand-name drug prices in the U.S. 鈥 more than three times the price in other developed countries 鈥 are related neither to the amount of research and development required to bring them to market nor their therapeutic value, recent research shows. Have drugmakers overplayed their hand?
蘑菇影院 Health News' 'What the Health?': Abortion Pill鈥檚 Legal Limbo Continues
A federal appeals court issued a split decision on whether the abortion pill mifepristone should remain on the market 鈥 rejecting a lower court鈥檚 decision to effectively cancel the drug鈥檚 FDA approval in 2000, while ordering the rollback of more recent rules that made the drug easier to obtain. Nothing changes immediately, however, as the Supreme Court blocked the lower court鈥檚 ruling in the spring. It will be up to the high court to determine whether the pill remains available in the U.S. and under which conditions. Sarah Karlin-Smith of the Pink Sheet, Alice Miranda Ollstein of Politico, and Shefali Luthra of The 19th join 蘑菇影院 Health News鈥 chief Washington correspondent, Julie Rovner, to discuss these issues and more. Plus, for 鈥渆xtra credit,鈥 the panelists suggest health policy stories they read this week they think you should read, too.
Journalists Sum Up the Costs to Patients of New Weight Loss Drugs and Hospital Mergers
蘑菇影院 Health News and California Healthline staff made the rounds on national and local media this week to discuss their stories. Here鈥檚 a collection of their appearances.
Watch: As Opioid Settlement Money Starts to Flow, States and Local Officials Debate How to Use It
PBS NewsHour featured 蘑菇影院 Health News鈥 Aneri Pattani as it reported on how this debate is playing out in North Carolina and Ohio.
New Alzheimer鈥檚 Drug Raises Hopes 鈥 Along With Questions
Clinics serving Alzheimer鈥檚 patients are working out the details of who will get treated with the new drug Leqembi. It won鈥檛 be for everyone with memory-loss symptoms.
蘑菇影院 Health News' 'What the Health?': On Abortion Rights, Ohio Is the New Kansas
Nearly a year to the day after Kansas voters surprised the nation by defeating an anti-abortion ballot question, Ohio voters defeated a similar, if cagier, effort to limit access in that state. This week, they rejected an effort to raise the threshold for approval of future ballot measures from a simple majority, which would have made it harder to protect abortion access with yet another ballot question come November. Meanwhile, the number of Americans without health insurance has dropped to an all-time low, though few noticed. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Rachel Roubein of The Washington Post, and Emmarie Huetteman of 蘑菇影院 Health News join 蘑菇影院 Health News鈥 chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews Kate McEvoy, executive director of the National Association of Medicaid Directors, about how the 鈥淢edicaid unwinding鈥 is going, as millions have their eligibility for coverage rechecked.
Seeking Medicare Coverage for Weight Loss Drugs, Pharma Giant Courts Black Influencers
Novo Nordisk, the dominant company in the multibillion-dollar market for weight loss drugs, focuses on Black lawmakers and opinion leaders to spread the message that obesity is a chronic disease that needs treatment.
Survey: Americans Want Weight Loss Drugs Despite High Cost
A new poll reveals enthusiasm for a pricey new generation of weight loss drugs, but interest drops if users potentially have to deal with weekly injections, lack of insurance coverage, or a need to continue the medications indefinitely to avoid regaining weight.
The Real Costs of the New Alzheimer鈥檚 Drug, Most of Which Will Fall to Taxpayers
The annual cost of lecanemab treatment quadruples if the expense of brain scans to monitor for bleeds and other associated care is factored in. The full financial toll likely puts it beyond reach for low-income seniors at risk of Alzheimer鈥檚, experts say.
蘑菇影院 Health News' 'What the Health?': Another Try for Mental Health 鈥楶arity鈥
President Joe Biden is kicking off his reelection campaign in part by trying to finish a decades-long effort to establish parity in insurance benefits between mental and physical health. Meanwhile, House Republicans are working to add abortion and other contentious amendments to must-pass spending bills. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Anna Edney of Bloomberg, and Sarah Karlin-Smith of the Pink Sheet join 蘑菇影院 Health News鈥 chief Washington correspondent, Julie Rovner, to discuss these issues and more. Also this week, Rovner interviews 蘑菇影院 Health News鈥 C茅line Gounder about her podcast 鈥淓pidemic.鈥 The new season focuses on the successful public health effort to eradicate smallpox.
